EP2350664
TREATMENT OF CANCER USING THE HYPOXIA ACTIVATED PRODRUG TH-302 IN COMBINATION WITH DOCETAXEL OR PEMETREXED
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.10.2009:
19.5.2021:
09822657.4
:
20.10.2029
:
TREATMENT OF CANCER USING THE HYPOXIA ACTIVATED PRODRUG TH-302 IN COMBINATION WITH DOCETAXEL OR PEMETREXED
21.10.2009
19.5.2021
:
ImmunoGenesis, Inc.:
909 Fannin St Suite 2000, Houston TX 77010, US
:
CURD, John G.:
Burlingame California 94010, US
:
KROLL, Stewart:
Oakland California 94618, US
:
MATTEUCCI, Mark:
Portola Valley California 94028, US
:
HART, Charles P.:
Mountain View California 94040, US
:
DUAN, Jian-Xin:
Foster City, CA 94404, US
:
SUN, Jessica D.:
Fremont, CA 94539, US
:
107253 P:
21.10.2008:
US
:
118368 P:
26.11.2008:
US
:
150700 P:
6.2.2009:
US
:
151163 P:
9.2.2009:
US
:
244172 P:
21.9.2009:
US
:
US2009061541:
21.10.2009
:
A61K 31/337, A61K 31/4985, A61K 31/513, A61K 31/519, A61K 31/555, A61K 31/675, A61K 31/704, A61K 31/7068, A61P 35/00, A61K 9/00, A61P 1/00, A61P 1/18, A61P 13/08, A61P 17/00, A61P 43/00, A61K 45/06, A61K 47/26, A61K 33/24